MARKET

NSTG

NSTG

NanoString Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

61.94
+2.17
+3.63%
After Hours: 61.94 0 0.00% 16:00 07/28 EDT
OPEN
60.00
PREV CLOSE
59.77
HIGH
62.74
LOW
60.00
VOLUME
217.07K
TURNOVER
--
52 WEEK HIGH
86.42
52 WEEK LOW
32.50
MARKET CAP
2.80B
P/E (TTM)
-25.5149
1D
5D
1M
3M
1Y
5Y
Hedge Funds Aren’t Crazy About NanoString Technologies Inc (NSTG) Anymore
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds...
Insider Monkey · 07/13 17:16
NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will release second quarter 2021 operating results after the close of the market on Wednesday, ...
Business Wire · 07/08 10:00
Looking Into NanoString Technologies's Return On Capital Employed
During Q1, NanoString Technologies's (NASDAQ:NSTG) reported sales totaled $31.62 million. Despite a 35.65% in earnings, the company posted a loss of $25.87 million. In Q4, NanoString Technologies brought in $36.26 million in sales but lost $19.07 million i...
Benzinga · 06/24 13:52
NanoString Launches nCounter Stem Cell Characterization Panel To 'Advance the Development of Stem Cell Therapy'
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® Stem Cell Characterization Panel for the
Benzinga · 06/22 10:02
NanoString forms alliance to optimize cell therapies in cancer
NanoString Technologies (NSTG) and the Parker Institute for Cancer Immunotherapy ((PICI)) are collaborating on an expansive molecular characterization project for cellular therapies.The collaboration will define the characteristics that make a
Seekingalpha · 06/15 10:19
NanoString And Parker Institute For Cancer Immunotherapy Collaborate To 'Optimize Cell Therapies to Treat Cancer'; Collaboration Will Utilize nCounter Analysis System
Collaboration Will Utilize the nCounter Analysis System to Characterize CAR-T Regimens Designed to Improve Patient Outcomes NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for
Benzinga · 06/15 10:01
NanoString Technologies Insights: Return On Capital Employed
In Q1, NanoString Technologies (NASDAQ:NSTG) posted sales of $31.62 million. Earnings were up 35.65%, but NanoString Technologies still reported an overall loss of $25.87 million. In Q4, NanoString Technologies brought in $36.26 million in sales but lost $...
Benzinga · 06/08 15:35
Shareholders Are Thrilled That The NanoString Technologies (NASDAQ:NSTG) Share Price Increased 283%
NanoString Technologies, Inc. ( NASDAQ:NSTG ) shareholders might be concerned after seeing the share price drop 29% in...
Simply Wall St. · 06/02 09:39
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NSTG. Analyze the recent business situations of NanoString Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NSTG stock price target is 74.75 with a high estimate of 85.00 and a low estimate of 65.00.
EPS
Institutional Holdings
Institutions: 259
Institutional Holdings: 63.49M
% Owned: 140.42%
Shares Outstanding: 45.21M
TypeInstitutionsShares
Increased
59
3.64M
New
35
2.87M
Decreased
73
5.51M
Sold Out
23
754.80K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.84%
Healthcare Equipment & Supplies
+0.75%
Key Executives
Non-Executive Chairman/Independent Director
William Young
President/Chief Executive Officer/Director
R. Bradley Gray
Chief Financial Officer
K. Thomas Bailey
Senior Vice President/Chief Scientific Officer
Joseph Beechem
Senior Vice President/Director of Sales/Director of Marketing
John Brown
Independent Director
Elisha Finney
Independent Director
Janet George
Independent Director
Robert Hershberg
Independent Director
Don Kania
Independent Director
Kirk Malloy
Independent Director
Gregory Norden
Independent Director
Dana Rollison
Independent Director
Charles Waite
No Data
About NSTG
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.

Webull offers kinds of NanoString Technologies Inc stock information, including NASDAQ:NSTG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSTG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NSTG stock methods without spending real money on the virtual paper trading platform.